{"title":"选定的血液学摘要。","authors":"Lowell S Kabnick, Katheen Ozsvath, Jorge H Ulloa","doi":"10.1177/02683555221137528","DOIUrl":null,"url":null,"abstract":"The authors performed a systematic review and meta-analysis to determine the evidence regarding the safety and ef fi cacy of direct oral anticoagulants (DOACs) compared to vitamin K antagonists (VKAs) in the treatment of cerebral venous thrombosis (CVT). A total of 17 studies were reviewed. There was no statisticaldifferenceinrecurrentvenousthromboembolism(VTE) risk,partialorfullthrombusrecanalization,andgoodfunctional","PeriodicalId":20139,"journal":{"name":"Phlebology","volume":"37 10","pages":"756-758"},"PeriodicalIF":1.6000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Selected phlebological abstracts.\",\"authors\":\"Lowell S Kabnick, Katheen Ozsvath, Jorge H Ulloa\",\"doi\":\"10.1177/02683555221137528\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The authors performed a systematic review and meta-analysis to determine the evidence regarding the safety and ef fi cacy of direct oral anticoagulants (DOACs) compared to vitamin K antagonists (VKAs) in the treatment of cerebral venous thrombosis (CVT). A total of 17 studies were reviewed. There was no statisticaldifferenceinrecurrentvenousthromboembolism(VTE) risk,partialorfullthrombusrecanalization,andgoodfunctional\",\"PeriodicalId\":20139,\"journal\":{\"name\":\"Phlebology\",\"volume\":\"37 10\",\"pages\":\"756-758\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2022-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Phlebology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/02683555221137528\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phlebology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/02683555221137528","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
The authors performed a systematic review and meta-analysis to determine the evidence regarding the safety and ef fi cacy of direct oral anticoagulants (DOACs) compared to vitamin K antagonists (VKAs) in the treatment of cerebral venous thrombosis (CVT). A total of 17 studies were reviewed. There was no statisticaldifferenceinrecurrentvenousthromboembolism(VTE) risk,partialorfullthrombusrecanalization,andgoodfunctional
期刊介绍:
The leading scientific journal devoted entirely to venous disease, Phlebology is the official journal of several international societies devoted to the subject. It publishes the results of high quality studies and reviews on any factor that may influence the outcome of patients with venous disease. This journal provides authoritative information about all aspects of diseases of the veins including up to the minute reviews, original articles, and short reports on the latest treatment procedures and patient outcomes to help medical practitioners, allied health professionals and scientists stay up-to-date on developments.
Print ISSN: 0268-3555